U.S. Markets closed

Today’s Research Reports on Neovasc, Nuvo Pharmaceuticals, Baylin Technologies and Canopy Growth

NEW YORK, NY / ACCESSWIRE / May 11, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Neovasc Inc.
https://rdinvesting.com/news/?ticker=NVCN.TO

Nuvo Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=NRI.TO

Baylin Technologies Inc.
https://rdinvesting.com/news/?ticker=BYL.TO

Canopy Growth Corporation
https://rdinvesting.com/news/?ticker=WEED.TO

Neovasc's stock jumped 8.33% Thursday, to close the day at $0.065. The stock recorded a trading volume of 4,974,668 shares, which was below its three months average volume of 5,322,598 shares. In the last year, Neovasc's shares have traded in a range of 0.04 - 2.32. The share price has gained 62.50% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.077 is below its 200-day moving average of $0.63. Shares of Neovasc have fallen approximately 90.67 percent year-to-date.

Access RDI's Neovasc Inc. Research Report at:
https://rdinvesting.com/news/?ticker=NVCN.TO

On Thursday, shares of Nuvo Pharmaceuticals recorded a trading volume of 7,200 shares, which was below the three months average volume of 8,991 shares. The stock ended the day 1.67% lower at 2.95. The stock is currently trading 38.28% below its 52 week high with a 52 week trading range of 2.94 - 4.78. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $3.27 is below its 200-day moving average of $3.60. Shares of the company are trading at a Price to Earnings ratio of 23.79. Shares of Nuvo Pharmaceuticals have fallen approximately 20.27 percent year-to-date.

Access RDI's Nuvo Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=NRI.TO

Baylin Technologies' stock moved 3.08% lower Thursday, to close the day at $3.46. The stock recorded a trading volume of 3,700 shares, which was below its three months average volume of 26,950 shares. In the last year, Baylin Technologies' shares have traded in a range of 1.87 - 4.12. The share price has gained 85.03% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $3.66 is greater than its 200-day moving average of $3.27. Shares of Baylin Technologies have gained approximately 0.58 percent year-to-date.

Access RDI's Baylin Technologies Inc. Research Report at:
https://rdinvesting.com/news/?ticker=BYL.TO

On Thursday, shares of Canopy Growth recorded a trading volume of 1,380,550 shares, which was below the three months average volume of 4,792,880 shares. The stock ended the day 0.40% lower at 29.75. The share price has gained 352.13% from its 52 week low with a 52 week trading range of 6.58 - 44.00. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $29.79 is greater than its 200-day moving average of $26.83. Shares of Canopy Growth have gained approximately 0.03 percent year-to-date.

Access RDI's Canopy Growth Corporation Research Report at:
https://rdinvesting.com/news/?ticker=WEED.TO

Our Actionable Research on Neovasc Inc. (TSX:NVCN.TO), Nuvo Pharmaceuticals Inc. (TSX:NRI.TO), Baylin Technologies Inc. (TSX:BYL.TO) and Canopy Growth Corporation (TSX:WEED.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com